Source: Annual Congress 2013 –Epidemiology of respiratory disease
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Gray, D. Lambrelli, D. Eriksson, S. Munson, R. Wasiak, M. Raluy, B. Myrvang, R. R. Reinert (Collegeville, United States Of America; London, United Kingdom; Ullevål, Norway; Paris, France). Incidence of hospitalized all-cause pneumonia, and serotype distribution of hospitalized streptococcus pneumoniae pneumonia in Norway 2008-2009. Eur Respir J 2013; 42: Suppl. 57, 4204

Member's Comments

No comment yet.

Related content which might interest you: The burden of hospitalized all-cause and pneumococcal pneumonia in Spain (2010) Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Risk of hospitalization due to pneumococcal pneumonia in adults in Spain. The CORIENNE study Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Hospital admissions of adults with community-acquired pneumonia in Portugal between 2000 and 2009 Source: Eur Respir J 2013; 41: 1141-1146 Year: 2013 The burden of multi-cause and pneumococcal pneumonia hospitalisations in the RhÔne-Alpes region, France (2005–2010) Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 An outbreak of streptococcus pneumonia serotype 1 pneumonia in a UK primary school Source: Annual Congress 2007 - Paediatric respiratory epidemiology: rare diseases, infectious diseases and asthma Year: 2007 Do school holidays affect adult pneumococcal community acquired pneumonia incidence? Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Cost and outcomes of pneumococcal community-acquired pneumonia among adults in the United Kingdom Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Evolution of serotype coverages of 23- and 7-valent pneumococcal vacciness for S. pneumonia isolates from Spanish middle age and older adults with pneumonia, 2002-2007 Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Health care-associated pneumonia and community-acquired pneumonia: A single-center experience Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Is duration of stay in hospital affected by influenza season in pneumonia patients? Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Increasing prevalence of complicated pneumonia and pneumococcal related hemolytic uremic syndrome despite territory-wide program of pneumococcal conjugated vaccination (PCV-7) program in children Source: International Congress 2014 – Paediatric epidemiology: wheeze, asthma and other respiratory diseases Year: 2014 Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia Source: Eur Respir J 2006 Oct 01;28(4):816-823 Year: 2006 Bacterial features of bacteremia in pediatric patients with pneumonia at Children hospital No. 1, Vietnam Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others Year: 2019 A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia Source: Eur Respir J 2011; 37: 1151-1157 Year: 2011 LATE-BREAKING ABSTRACT: Pneumococcal serotypes causing community-acquired pneumonia (CAP) among hospitalized adults in Spain using a new urinary antigen detection (UAD) test. The CAPA study Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics? Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 5-year weekly monitoring of community-acquired pneumonia incidence and mortality Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016 Contribution of H1N1 to community-acquired pneumonia admissions, Edinburgh July-December 2009 Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology Year: 2010